“…On the other hand, we had reported the isolation and identification of eleven phenolic compounds from Egyptian propolis for the first time; these compounds were pinostrobin, izalpinin, tectochrysin, pinocembrin, galangin, chrysin, quercetin-3,3'-di-O-methyl ether, kaempferol-3-O-methyl ether, quercetin-3,7-di-Omethyl ether, isoferulic acid and galangin-5-O-methyl ether (Ibrahim et al, 2014) In the present study, tectochrysin and quercetin-3,3'di-O-methylether, were tested for their anticancer activity on human breast cancer (MCF-7) and colorectal adenocarcinoma (Caco-2) cell lines. The choice of these two compounds was based on that there were no previous studies performed to assay their anticancer effect on MCF-7 or Caco-2 cell lines using neutral red uptake (NRU) method, except one study performed on tectochrysin isolated from Friesodielsia discolor which was tested for its cytotoxic activity on MCF-7 cell line and it exhibited cytotoxicity with IC 50 = 4.49 µg/ml, using the sulforhodamine B (SRB) assay (Prawat et al, 2012) Moreover, as several studies had revealed that ethanol extract of propolis samples collected abroad exhibited anticancer activity on MCF-7 (Kamiya et al, 2012;Xuan et al, 2014;Omene, 2013) and Caco-2 ( (Russo et al, 2004;Choudhari et al, 2013;Ishihara et al, 2009) cell lines, the present study is considered to be the first to screen the anticancer activity of Egyptian propolis against MCF-7 and Caco-2 cell lines.…”